Active Ingredient (In Each Tablet)
Levocetirizine dihydrochloride USP 5 mg
The following Structured Product Label (SPL) was submitted to the FDA by Micro Labs Limited for the product Levocetirizine Dihydrochloride (NDC 42571-312). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, do not use, ask a doctor before use if you have, when using this product, stop use and ask a doctor if, if pregnant or breast-feeding:, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Levocetirizine dihydrochloride USP 5 mg
Antihistamine
temporarily relieves these symptoms due to hay fever or other respiratory allergies:
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
| adults 65 years of age and older |
|
| adults and children 12-64 years of age |
|
| children 6-11 years of age |
|
| children under 6 years of age |
|
| consumers with kidney disease |
|
hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol 400 and titanium dioxide
call1-855-839-8195
MICRO LABS LIMITED
Container
NDC- 42571-312-90
Levocetirizine dihydrochloride Tablets USP
5mg
Antihistamine
90 Tablets MICRO LABS
NDC- 42571-312-90
Levocetirizine dihydrochloride Tablets USP
5mg
Antihistamine
90 Tablets MICRO LABS
NDC- 42571-312-90
Levocetirizine dihydrochloride Tablets USP
5mg
Antihistamine
90 Tablets MICRO LABS
NDC- 42571-312-90
Levocetirizine dihydrochloride Tablets USP
5mg
Antihistamine
90 Tablets MICRO LABS
* Please review the disclaimer below.